Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01762124 · ClinicalTrials.gov registry record · NA
Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)
A NA study, sponsored by Medtronic Heart Valves.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01762124 is a NA study that has completed, run by Medtronic Heart Valves. The registered enrollment target is 20 participants.
The verdict
NCT01762124, a NA study, has completed, sponsored by Medtronic Heart Valves.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this early feasibility study is to determine how a new transcatheter pulmonary valve will move and perform once implanted in the right ventricular outflow tract.
Interventions
- DEVICE Native Outflow Tract TPV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-10 |
| Est. Completion | 2020-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01762124
The ClinicalTrials.gov registry entry for NCT01762124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Heart Valves, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Native Outflow Tract TPV is the first listed.
NCT01762124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01762124 about?
NCT01762124 is a clinical study titled "Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)". The purpose of this early feasibility study is to determine how a new transcatheter pulmonary valve will move and perform once implanted in the right ventricular outflow tract.
What is the current status of trial NCT01762124?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-10. Estimated completion is 2020-07.
What interventions are being tested in trial NCT01762124?
The interventions under investigation include: Native Outflow Tract TPV (DEVICE).
Who is sponsoring clinical trial NCT01762124?
This trial is sponsored by Medtronic Heart Valves, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.